High-throughput splicing assays identify known and novel WT1 exon 9 variants in nephrotic syndrome
Smith, C.; Burugula, B. B.; Dunn, I.; Aradhya, S.; Kitzman, J.; Lai Yee, J.
Show abstract
Frasier Syndrome (FS) is a rare Mendelian form of nephrotic syndrome caused by variants which disrupt the proper splicing of WT1. This key transcription factor gene is alternatively spliced at exon 9 to produce two isoforms ("KTS+" and "KTS-"), which are normally expressed in the kidney at a [~]2:1 (KTS+:KTS-) ratio. FS results from variants that reduce this ratio by disrupting the splice donor of the KTS+ isoform. FS is extremely rare, and it is unclear whether any variants beyond the eight already known could cause FS. To prospectively identify other splicing-disruptive variants, we leveraged a massively parallel splicing assay. We tested every possible single nucleotide variant (n=519) in and around WT1 exon 9 for effects upon exon inclusion and KTS+/- ratio. Splice disruptive variants made up 11% of the tested point variants overall, and were tightly concentrated near the canonical acceptor and the KTS+/- alternate donors. Our map successfully identified all eight known FS or focal segmental glomerulosclerosis variants and 16 additional novel variants which were comparably disruptive to these known pathogenic variants. We also identified 19 variants that, conversely, increased the KTS+/KTS- ratio, of which two are observed in unrelated individuals with 46,XX ovotesticular disorder of sex development (46,XX OTDSD). This splicing effect map can serve as functional evidence to guide the clinical interpretation of newly observed variants in and around WT1 exon 9.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- High-throughput splicing assays identify missense and silent splice-disruptive POU1F1 variants underlying pituitary hormone deficiency 96%
- Advanced variant classification framework reduces the false positive rate of predicted loss of function (pLoF) variants in population sequencing data 96%
- Transcriptome-wide outlier approach identifies individuals with minor spliceopathies 95%
Similar papers in this journal
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 94%
- Identification and validation of novel candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas 93%
- When splicing is not all or none: Implications for variant classification 93%
Similar papers in this journal
- Informing Variant Assessment using Structured Evidence from Prior Classifications (PS1, PM5, and PVS1 Sequence Variant Interpretation Criteria) 95%
- Utility of genome sequencing and group-enrichment to support splice variant interpretation in Marfan syndrome 95%
- Mapping RNA splicing variations in clinically-accessible and non-accessible tissues to facilitate Mendelian disease diagnosis using RNA-seq 95%
Similar papers in this journal
- ParSE-seq: A Calibrated Multiplexed Assay to Facilitate the Clinical Classification of Putative Splice-altering Variants 95%
- Exome-wide analysis of congenital kidney anomalies reveals new genes and shared architecture with developmental disorders 94%
- Saturation genome editing of DDX3X clarifies pathogenicity of germline and somatic variation 94%
Similar papers in this journal
- 3-hour genome sequencing and targeted analysis to rapidly assess genetic risk 93%
- Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity 93%
- Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.